CMB International Raises INNOSCIENCE Target Price to HK$75, Keeps Buy Rating

Stock News
04/02

CMB International has released a research report significantly raising the target price for INNOSCIENCE (02577) by 53.1% from HK$49 to HK$75, while maintaining a "Buy" rating. The report highlights the company's fiscal year 2025 results, which showed revenue increasing by 46.4% year-over-year to RMB 1.2 billion, with gross margin turning positive to 7.3%. Adjusted EBITDA also turned positive, marking the company's first significant operational inflection point. The improvement in profitability was primarily driven by ongoing capacity expansion, with monthly wafer capacity reaching 20,000 units by 2025, alongside simultaneous improvements in capacity utilization and yield rates. Beyond financial performance, fiscal year 2025 was also a crucial year for the company's commercial progress, including: 1) deeper collaboration with leading AI clients such as NVIDIA and Google on 800V DC power architecture; 2) initial expansion into the humanoid robotics sector through a 100V integrated GaN driver for joint modules; and 3) solid advancements in the automotive business, progressing from volume shipments of OBC/DC-DC converters to the initial verification stage for main drive inverters.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10